We use cookies for a better user experience. Read our Privacy Policy

I Agree

Coal Workers’ Pneumoconiosis Treatment Market

Coal Workers’ Pneumoconiosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021 - 2031

Coal Workers’ Pneumoconiosis Treatment Market: Introduction

  • Coal worker’s pneumoconiosis (CWP), or black lung disease, is caused due to working in coal mines over a prolonged period, which leads to difficulty in breathing along with scarring of the lungs.
  • CWP develops when the person breathes in coal dust particles that travel into the bronchioles. The dust also enters into the alveoli. Subsequently, the dust residues settle in the lungs, triggering an inflammatory response by the body in an attempt to remove them. This leads to the scarring of lung tissue, which causes coal worker’s pneumoconiosis (CWP).
  • The coal workers’ pneumoconiosis treatment market can be segmented based on type, diagnosis, treatment, route of administration, end-user, and region. Based on type, the market can be classified into simple coal workers’ pneumoconiosis and complicated coal workers’ pneumoconiosis. Based on the treatment, the market can be categorized into medication, oxygen therapy, pulmonary rehabilitation, and lung transplant. The medication segment can be further sub-segmented into inhaled medications, antibiotics, vaccine, corticosteroids, and others. In terms of route of administration, the coal Workers’ pneumoconiosis treatment market can be classified into inhalation, oral & others. Based on diagnosis, the market can be split into X-Ray, pulmonary function test, and CT scan. Based on end-user, the market can be bifurcated into as homecare, hospitals, specialty clinics, and ambulatory surgical centers.

Opportunities of Global Coal Workers’ Pneumoconiosis Treatment Market

  • Increase in prevalence of coal workers’ pneumoconiosis is a key factor that is estimated to propel the market during the forecast period. Moreover, rise in mining activities and an increase in research and development and healthcare expenditures further propel the market.
  • Rise in geriatric population and government initiatives regarding awareness about the disease is further boosting the coal workers’ pneumoconiosis treatment market
  • However, lack of awareness, higher costs of surgical therapeutics options and restricted availability of medicinal treatment along with high costs of lung transplantation and stem cell therapy are anticipated to restrain the coal workers’ pneumoconiosis treatment market

North America to Capture Major Share of Global Coal Workers’ Pneumoconiosis Treatment Market

  • North America dominated the global coal workers’ pneumoconiosis treatment market due to the well-established healthcare sector and huge patient pool in the region. Furthermore, rising healthcare expenditure and presence of numerous players, including Medtronic & General Electric, propel the coal workers’ pneumoconiosis treatment market in North America.
  • Europe follows North America in terms of share of the global coal workers’ pneumoconiosis treatment market. Increase in government support, huge patient pool, and improved healthcare infrastructure are key factors driving the coal workers’ pneumoconiosis treatment market in the region.
  •  The market in Asia Pacific is estimated to expand at a rapid pace owing to an increase in prevalence of coal workers’ pneumoconiosis along with a rise in awareness about the disease in the region

Key Players Operating in Global Coal Workers’ Pneumoconiosis Treatment Market

The global coal workers’ pneumoconiosis treatment market is highly fragmented, with the presence of various key players. A large number of manufacturers hold a major share in their respective regions. Major players operating in the global coal workers’ pneumoconiosis treatment market are:

  • Abbott
  • Novartis AG
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • Teva Pharmaceutical Industries Ltd
  • AstraZeneca
  • Medtronic
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd

Global Coal Workers’ Pneumoconiosis Treatment Market: Research Scope

Global Coal Workers’ Pneumoconiosis Treatment Market, by Type

  • Simple coal workers’ pneumoconiosis
  • Complicated coal workers’ pneumoconiosis

Global Coal Workers’ Pneumoconiosis Treatment Market, by Diagnosis

  • X-Ray
  • Pulmonary Function Test
  • CT Scan

Global Coal Workers’ Pneumoconiosis Treatment Market, by Treatment

  • Medication
    • Inhaled Medications
    • Antibiotics
    • Vaccine
    • Corticosteroids
    • Others
  • Oxygen Therapy
  • Pulmonary Rehabilitation
  • Lung Transplant

Global Coal Workers’ Pneumoconiosis Treatment Market, by Route of Administration

  • Inhalation
  • Oral
  • Others

Global Coal Workers’ Pneumoconiosis Treatment Market, by End-user

  • Homecare
  • Hospitals
  • Specialty Clinics
  • Ambulatory surgical centers

Global Coal Workers’ Pneumoconiosis Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East &Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Coal Workers’ Pneumoconiosis Treatment Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

NA

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

215

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved